![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/hanall-biopharma-appoints-christopher-w-slavinsky-as-chief-business-development-and-legal-officer-302196473.html
https://www.prnewswire.com/news-releases/hanall-biopharma-signs-licensing-agreement-with-turn-biotechnologies-to-develop-novel-treatments-for-eye-and-ear-diseases-302156468.html
https://www.prnewswire.com/news-releases/hanall-biopharma-announces-initiation-of-phase-iii-randomized-double-masked-vehicle-controlled-velos-4-trial-evaluating-tanfanercept-for-treatment-of-dry-eye-disease-302135438.html
https://www.prnewswire.com/news-releases/hanall-biopharma-reports-q1-2024-financial-results-and-provides-business-update-302131240.html
https://www.prnewswire.com/news-releases/hanall-biopharma-reports-full-year-2023-financial-results-and-provides-business-update-302095695.html
https://www.prnewswire.com/news-releases/hanall-biopharma-daewoong-pharmaceutical-and-nurron-pharmaceuticals-to-showcase-ongoing-parkinsons-disease-program-at-the-7th-annual-sachs-associates-neuroscience-innovation-forum-302019893.html
https://www.prnewswire.com/news-releases/hanall-biopharmas-partner-nurron-pharmaceuticals-incorporated-appoints-dr-almira-chabi-md-egmp-to-board-of-directors-302010850.html
https://www.prnewswire.com/news-releases/hanall-biopharma-reports-third-quarter-2023-financial-results-and-provides-a-business-update-301968423.html
https://www.prnewswire.com/news-releases/hanall-biopharma-daewoong-pharmaceutical-and-nurron-pharmaceuticals-initiate-first-in-human-phase-1-clinical-study-of-hl192-301954586.html
https://www.prnewswire.com/news-releases/hanall-biopharma-reports-second-quarter-2023-financial-results-and-provides-a-business-update-301887101.html